Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

M. G. Kris, Richard J. Gralla, N. Martini, L. V. Stampleman, M. T. Burke

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

Original languageEnglish (US)
Pages (from-to)407-415
Number of pages9
JournalHematology/Oncology Clinics of North America
Volume2
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Radiation
Drug Therapy
Combination Drug Therapy
Cisplatin
Lung Neoplasms
Research Personnel
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer. / Kris, M. G.; Gralla, Richard J.; Martini, N.; Stampleman, L. V.; Burke, M. T.

In: Hematology/Oncology Clinics of North America, Vol. 2, No. 3, 1988, p. 407-415.

Research output: Contribution to journalArticle

Kris, M. G. ; Gralla, Richard J. ; Martini, N. ; Stampleman, L. V. ; Burke, M. T. / Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer. In: Hematology/Oncology Clinics of North America. 1988 ; Vol. 2, No. 3. pp. 407-415.
@article{2a00e182de564526af7e3136b0235948,
title = "Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer",
abstract = "The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.",
author = "Kris, {M. G.} and Gralla, {Richard J.} and N. Martini and Stampleman, {L. V.} and Burke, {M. T.}",
year = "1988",
language = "English (US)",
volume = "2",
pages = "407--415",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

AU - Kris, M. G.

AU - Gralla, Richard J.

AU - Martini, N.

AU - Stampleman, L. V.

AU - Burke, M. T.

PY - 1988

Y1 - 1988

N2 - The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

AB - The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0023740706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023740706&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023740706

VL - 2

SP - 407

EP - 415

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 3

ER -